Vito Sasseville supported the Drug Safety groups at Bristol-Myers Squibb, Millennium Pharmaceuticals (Takeda), and the Novartis Institutes of Biomedical. Vito is recognized for his work in the safety assessment of ocular and is currently the owner of Coastal Pharmaceutical Consulting.